These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 9229146)

  • 1. Economic considerations in the care of patients with head and neck malignancies.
    Pfister DG; Ruchlin HS; Elkin EB
    Curr Opin Oncol; 1997 May; 9(3):241-6. PubMed ID: 9229146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical economics of head and neck malignancies.
    Sherman EJ; Ruchlin HS; Holden JS; Pfister DG
    Hematol Oncol Clin North Am; 1999 Aug; 13(4):867-81. PubMed ID: 10494519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Economic burden of head and neck cancer. A literature review.
    Lee JM; Turini M; Botteman MF; Stephens JM; Pashos CL
    Eur J Health Econ; 2004 Feb; 5(1):70-80. PubMed ID: 15452768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-Utility of Stepped Care Targeting Psychological Distress in Patients With Head and Neck or Lung Cancer.
    Jansen F; Krebber AM; Coupé VM; Cuijpers P; de Bree R; Becker-Commissaris A; Smit EF; van Straten A; Eeckhout GM; Beekman AT; Leemans CR; Verdonck-de Leeuw IM
    J Clin Oncol; 2017 Jan; 35(3):314-324. PubMed ID: 27918712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of a skilled nursing facility on the cost of surgical treatment of major head and neck tumors.
    Seikaly H; Calhoun KH; Stonestreet JS; Rassekh CH; Driscoll BP; Averyt P
    Arch Otolaryngol Head Neck Surg; 2001 Sep; 127(9):1086-8. PubMed ID: 11556857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modern methods to predict costs for the treatment and management of head and neck cancer patients: examples of methods used in the current literature.
    Wineland AM; Stack BC
    Curr Opin Otolaryngol Head Neck Surg; 2008 Apr; 16(2):113-6. PubMed ID: 18327029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defining value-driven care in head and neck oncology.
    Roman BR; Awad MI; Patel SG
    Curr Oncol Rep; 2015 Jan; 17(1):424. PubMed ID: 25416318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment patterns and economic burden of metastatic and recurrent locally-advanced head and neck cancer patients.
    Kim Le T; Winfree KB; Yang H; Marynchenko M; Yu AP; Frois C; Wu EQ
    J Med Econ; 2012; 15(4):786-95. PubMed ID: 22475042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Economic assessments of head and neck cancers: a review].
    Selke B; Allenet B; Bercez C; Bogillot O; Lebrun T; Lefebvre JL
    Bull Cancer; 2001 Aug; 88(8):759-64. PubMed ID: 11578944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-Effectiveness of Reduced Waiting Time for Head and Neck Cancer Patients due to a Lean Process Redesign.
    Simons PA; Ramaekers B; Hoebers F; Kross KW; Marneffe W; Pijls-Johannesma M; Vandijck D
    Value Health; 2015 Jul; 18(5):587-96. PubMed ID: 26297086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment costs for patients with head and neck cancer.
    Suen JY; Jackson MJ; Porr MJ
    Arch Otolaryngol; 1979 Mar; 105(3):160-3. PubMed ID: 420657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of hospital safety-net burden status on short-term outcomes and cost of care after head and neck cancer surgery.
    Genther DJ; Gourin CG
    Arch Otolaryngol Head Neck Surg; 2012 Nov; 138(11):1015-22. PubMed ID: 23165375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Economic analyses in squamous cell carcinoma of the head and neck: a review of the literature from a clinical perspective.
    de Souza JA; Santana IA; de Castro G; de Lima Lopes G; Tina Shih YC
    Int J Radiat Oncol Biol Phys; 2014 Aug; 89(5):989-996. PubMed ID: 25035201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The economics of squamous cell carcinoma of the head and neck.
    Menzin J; Lines LM; Manning LN
    Curr Opin Otolaryngol Head Neck Surg; 2007 Apr; 15(2):68-73. PubMed ID: 17413405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic review and evidence synthesis of non-cervical human papillomavirus-related disease health system costs and quality of life estimates.
    Ong KJ; Checchi M; Burns L; Pavitt C; Postma MJ; Jit M
    Sex Transm Infect; 2019 Feb; 95(1):28-35. PubMed ID: 30674687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct health-care cost of head and neck cancers: a population-based study in north-eastern Italy.
    Polesel J; Lupato V; Collarile P; Vaccher E; Fanetti G; Giacomarra V; Palazzari E; Furlan C; Matrone F; Navarria F; Gobitti C; Minatel E; Serraino D; Birri S; Franchin G
    Med Oncol; 2019 Feb; 36(4):31. PubMed ID: 30815763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methodologic issues in the comparison of microsurgical flaps/techniques in head and neck reconstruction.
    Thoma A; Sprague S
    Clin Plast Surg; 2005 Jul; 32(3):347-59, vi. PubMed ID: 15979474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Family pediatrics: report of the Task Force on the Family.
    Schor EL;
    Pediatrics; 2003 Jun; 111(6 Pt 2):1541-71. PubMed ID: 12777595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Making Implicit Assumptions Explicit in the Costing of Informal Care: The Case of Head and Neck Cancer in Ireland.
    Hanly P; Maguire R; Balfe M; O'Sullivan E; Sharp L
    Pharmacoeconomics; 2017 May; 35(5):591-601. PubMed ID: 28205149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inventory of economic evaluation of head and neck oncology from the German perspective.
    Kurzweg T; Knecht R
    Eur Arch Otorhinolaryngol; 2014 Oct; 271(10):2611-6. PubMed ID: 24402378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.